Conference Paper
Critical Analysis of Electromagnetic Hyperthermia Randomized Trials: Dubious Effect and Multiple Biases
Table 3
Patient characteristic and treatment summary from Jones et al. [
12] clinical trial.
| Characteristic | No HT () | HT () | Number of Patients | | % | Number of Patients | | % |
| Age | | | | | | | Median | | 59.3 | −7 years | 52.4 | | Range | | 38.4–83.8 | | | 18.2–90.9 | | Sex | | | | | | | Male | | 13 | | | 14 | | Female | | 39 | | | 42 | | Site of disease | | | | | | | Breast/chest wall | 33 | | 63 | 37 | | 66 | Head and neck | 6 | | 12 | 8 | | 14 | Melanoma | 6 | | 12 | 5 | | 9 | Other | 7 | | 13 | 6 | | 11 | Multiple HT fields | 7 | | 13 | 18 | | 32 | Prior XRT | 17 | | 33 | 22 | | 39 | RT dose, Gy (given on protocol) | | | | | | | Median | | 50 | +10% | 55 | | Range | | 18–70 | | | 20–70 | | Metastasis at enrollment | 17 of 51 | | 33 | 16 of 52 | | 31 | Additional systemic therapy | 34 | | 65 | 33 | | 59 | Hyperthermia dose, CEM 43°C | | | | | | | Median | | 0.74 | | | 14.3 | | Range | | 0.07–1.49 | | | 0.57–36.21 | |
|
|
Abbreviations: HT: hyperthermia; XRT: external radiation therapy; RT: radiation therapy; CEM: cumulative equivalent minutes.
|